<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="175619-2018"
            EDITION="2018078">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-180349-001</RECEPTION_ID>
      <DELETION_DATE>20190420</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>78</NO_OJ>
         <DATE_PUB>20180421</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 078-175619</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:175619-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>http://www.fhi.no</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33651600">Vaccines</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33651610">Diphtheria-pertussis-tetanus vaccines</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33651620">Diphtheria-tetanus vaccines</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33651670">Polio vaccines</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33651680">Hepatitis B vaccines</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO">NORGE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO">NORGE</n2016:CA_CE_NUTS>
         <VALUES>
            <VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="NOK">200000000.00</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180420</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="1">Ministry or any other national or federal authority</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="0">Prior information notice without call for competition</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="9">Not applicable</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="9">Not applicable</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B01</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Осло</TI_TOWN>
            <TI_TEXT>
               <P>Ваксини</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Očkovací látky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vacciner</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Impfstoffe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Όσλο</TI_TOWN>
            <TI_TEXT>
               <P>Εμβόλια</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccines</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vacunas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaktsiinid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Rokotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccins</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Osló</TI_TOWN>
            <TI_TEXT>
               <P>Vaccines</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Cjepiva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vakcinák</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccini</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Oslas</TI_TOWN>
            <TI_TEXT>
               <P>Vakcinos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vakcīnas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaċċini</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccins</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Szczepionki</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vacinas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vaccinuri</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Očkovacie látky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Cepiva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Vacciner</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Folkehelseinstituttet</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>41e3ab2c-4e8b-49f1-9763-1363e5a9227d</NOTICE_UUID>
      <F01_2014 CATEGORY="ORIGINAL" FORM="F01" LG="EN">
         <NOTICE TYPE="PRI_ONLY"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Folkehelseinstituttet</OFFICIALNAME>
               <NATIONALID>983 744 516</NATIONALID>
               <ADDRESS>Lovisenberggata 8</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0456</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Ole Andreas Fuglesang</CONTACT_POINT>
               <PHONE>+47 21076629</PHONE>
               <E_MAIL>ole.andreas.fuglesang@fhi.no</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>http://www.fhi.no</URL_GENERAL>
               <URL_BUYER>https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_TOOL>https://eu.eu-supply.com/dfo.asp</URL_TOOL>
            <CA_TYPE VALUE="MINISTRY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT ITEM="1">
            <TITLE>
               <P>Request for information, Hexavalent vaccine.</P>
            </TITLE>
            <REFERENCE_NUMBER>18/10763</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33651600"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>This is a Request for Information (RFI) regarding combination vaccine against Diptheria, Tetanus, Pertussis, Polio, Haemophilus influenzae type B and Hepatitis B (Hexavalent vaccine) suitable for use in the Norwegian child vaccination programme.</P>
            </SHORT_DESCR>
            <VAL_ESTIMATED_TOTAL CURRENCY="NOK">200000000.00</VAL_ESTIMATED_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651610"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651620"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651670"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33651680"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="NO"/>
               <MAIN_SITE>
                  <P>Oslo.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>This is a Request for Information (RFI) regarding combination vaccine against Diptheria, Tetanus, Pertussis, Polio, Haemophilus influenzae type B and Hepatitis B (Hexavalent vaccine) suitable for use in the Norwegian child vaccination programme.</P>
                  <P>The tender competition which was the basis for the Norwegian Institute of Public Health’s current contract for Hexavalent vaccine was carried out in 2016. 2 tender offers were received, of which one was rejected due to significant conditions related to the time of the first delivery.</P>
                  <P>The Norwegian Institute of Public Health now wants to procure information from the market regarding whether the market situation has changed since 2016. Feedback on this will be taken into consideration on whether to trigger an extension of the current contract or whether to implement a new tender competition.</P>
                  <P>We refer to the attached document “18-10763 RFI Heksavalent vaksine” [18-10763 RFI Hexavalent vaccine] for further information, with i.a. a description of the status of the existing contract, future vaccine need and time line as well as the specific questions that the Norwegian Institute of Public Health wants answered by the market through this RFI process.</P>
                  <P>A pre-requisite to be evaluated in any later tender competition will be that the offered vaccine has marketing authorisation in Norway at the time for the tender submission.</P>
                  <P>Input should primarily be sent within the deadline via the message function to this case in CTM electronic tender implementation tool (KGV). Alternatively, input can be sent via email to ole.andreas.fuglesang@fhi.no</P>
                  <P>We request that email is labelled with a clear reference to the case.</P>
                  <P>The deadline is stated in the notice.</P>
               </SHORT_DESCR>
               <INFO_ADD>
                  <P>NB: this RFI process is not to be considered as part of a possible later procurement process. Final decisions and choices regarding the procurement and the procurement process have not been made at the present time. The RFI and response will not obligate either the service provider or the Norwegian Institute of Public Health in relation to any later procurement.</P>
               </INFO_ADD>
            </OBJECT_DESCR>
            <DATE_PUBLICATION_NOTICE>2018-04-20</DATE_PUBLICATION_NOTICE>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <DATE_DISPATCH_NOTICE>2018-04-20</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F01_2014>
   </FORM_SECTION>
</TED_EXPORT>
